A detailed history of Allred Capital Management, LLC transactions in Novartis Ag stock. As of the latest transaction made, Allred Capital Management, LLC holds 2,246 shares of NVS stock, worth $255,527. This represents 0.09% of its overall portfolio holdings.

Number of Shares
2,246
Previous 2,249 0.13%
Holding current value
$255,527
Previous $217,000 10.14%
% of portfolio
0.09%
Previous 0.09%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$92.57 - $107.37 $277 - $322
-3 Reduced 0.13%
2,246 $239,000
Q1 2024

Apr 16, 2024

SELL
$95.27 - $108.47 $35,726 - $40,676
-375 Reduced 14.29%
2,249 $217,000
Q4 2023

Jan 12, 2024

SELL
$92.27 - $101.54 $22,698 - $24,978
-246 Reduced 8.57%
2,624 $264,000
Q1 2023

May 09, 2023

BUY
$80.03 - $92.81 $2,080 - $2,413
26 Added 0.91%
2,870 $264,000
Q1 2022

May 05, 2022

BUY
$80.11 - $90.62 $1,842 - $2,084
23 Added 0.82%
2,844 $249,000
Q2 2021

Aug 05, 2021

SELL
$85.24 - $94.15 $30,430 - $33,611
-357 Reduced 11.23%
2,821 $257,000
Q1 2021

May 06, 2021

SELL
$83.5 - $98.47 $5,594 - $6,597
-67 Reduced 2.06%
3,178 $271,000
Q4 2020

Jan 21, 2021

SELL
$78.07 - $94.43 $1,014 - $1,227
-13 Reduced 0.4%
3,245 $306,000
Q3 2020

Oct 14, 2020

SELL
$82.14 - $91.0 $985 - $1,092
-12 Reduced 0.37%
3,258 $283,000
Q2 2020

Aug 13, 2020

BUY
$80.93 - $91.1 $2,346 - $2,641
29 Added 0.89%
3,270 $285,000
Q1 2020

Apr 17, 2020

BUY
$70.67 - $99.01 $70 - $99
1 Added 0.03%
3,241 $267 Million
Q4 2019

Jan 13, 2020

SELL
$84.35 - $95.37 $8,350 - $9,441
-99 Reduced 2.96%
3,240 $306,000
Q3 2019

Oct 07, 2019

SELL
$85.54 - $94.26 $65,609 - $72,297
-767 Reduced 18.68%
3,339 $287,000
Q2 2019

Jul 18, 2019

SELL
$75.4 - $92.8 $8,595 - $10,579
-114 Reduced 2.7%
4,106 $378,000
Q1 2019

Apr 16, 2019

BUY
$75.32 - $86.15 $317,850 - $363,553
4,220 New
4,220 $400,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $245B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Allred Capital Management, LLC Portfolio

Follow Allred Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allred Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allred Capital Management, LLC with notifications on news.